BRIEF-Myriad Genetics announced new data "demonstrating utility" of prolaris test
May 12, 2017 at 07:28 AM EDT
* Myriad Genetics - announced new data "demonstrating utility" of prolaris test to predict 10-year risk of metastases in men treated for prostate cancer Source text for Eikon: Further company coverage:
